Vesicular nucleotide transporter (VNUT)

appearance of an actress on the stage of purinergic signaling

Yoshinori Moriyama, Miki Hiasa, Shohei Sakamoto, Hiroshi Omote, Masatoshi Nomura

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Vesicular storage of ATP is one of the processes initiating purinergic chemical transmission. Although an active transport mechanism was postulated to be involved in the processes, a transporter(s) responsible for the vesicular storage of ATP remained unidentified for some time. In 2008, SLC17A9, the last identified member of the solute carrier 17 type I inorganic phosphate transporter family, was found to encode the vesicular nucleotide transporter (VNUT) that is responsible for the vesicular storage of ATP. VNUT transports various nucleotides in a membrane potential-dependent fashion and is expressed in the various ATP-secreting cells. Mice with knockout of the VNUT gene lose vesicular storage and release of ATP from neurons and neuroendocrine cells, resulting in blockage of the initiation of purinergic chemical transmission. Thus, VNUT plays an essential role in the vesicular storage and release of ATP. The VNUT knockout mice exhibit resistance for neuropathic pain and a therapeutic effect against diabetes by way of increased insulin sensitivity. Thus, VNUT inhibitors and suppression of VNUT gene expression may be used for therapeutic purposes through suppression of purinergic chemical transmission. This review summarizes the studies to date on VNUT and discusses what we have learned about the relevance of vesicular ATP release as a potential drug target.

Original languageEnglish
Pages (from-to)1-18
Number of pages18
JournalPurinergic Signalling
DOIs
Publication statusAccepted/In press - Jun 14 2017

Fingerprint

Nucleotides
Adenosine Triphosphate
Knockout Mice
Phosphate Transport Proteins
Neuroendocrine Cells
Active Biological Transport
Neuralgia
Therapeutic Uses
Membrane Potentials
Insulin Resistance
Gene Expression
Neurons
Pharmaceutical Preparations
Genes

Keywords

  • Allosteric inhibitor
  • ATP
  • Cl dependence
  • Diabetes
  • Ketone body
  • Metabolism
  • Neuropathic pain
  • Purinegic signaling
  • Vesicular nucleotide transporter
  • VNUT

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience
  • Cell Biology

Cite this

Vesicular nucleotide transporter (VNUT) : appearance of an actress on the stage of purinergic signaling. / Moriyama, Yoshinori; Hiasa, Miki; Sakamoto, Shohei; Omote, Hiroshi; Nomura, Masatoshi.

In: Purinergic Signalling, 14.06.2017, p. 1-18.

Research output: Contribution to journalArticle

@article{016a798a9d114860850be7de4c4bd815,
title = "Vesicular nucleotide transporter (VNUT): appearance of an actress on the stage of purinergic signaling",
abstract = "Vesicular storage of ATP is one of the processes initiating purinergic chemical transmission. Although an active transport mechanism was postulated to be involved in the processes, a transporter(s) responsible for the vesicular storage of ATP remained unidentified for some time. In 2008, SLC17A9, the last identified member of the solute carrier 17 type I inorganic phosphate transporter family, was found to encode the vesicular nucleotide transporter (VNUT) that is responsible for the vesicular storage of ATP. VNUT transports various nucleotides in a membrane potential-dependent fashion and is expressed in the various ATP-secreting cells. Mice with knockout of the VNUT gene lose vesicular storage and release of ATP from neurons and neuroendocrine cells, resulting in blockage of the initiation of purinergic chemical transmission. Thus, VNUT plays an essential role in the vesicular storage and release of ATP. The VNUT knockout mice exhibit resistance for neuropathic pain and a therapeutic effect against diabetes by way of increased insulin sensitivity. Thus, VNUT inhibitors and suppression of VNUT gene expression may be used for therapeutic purposes through suppression of purinergic chemical transmission. This review summarizes the studies to date on VNUT and discusses what we have learned about the relevance of vesicular ATP release as a potential drug target.",
keywords = "Allosteric inhibitor, ATP, Cl dependence, Diabetes, Ketone body, Metabolism, Neuropathic pain, Purinegic signaling, Vesicular nucleotide transporter, VNUT",
author = "Yoshinori Moriyama and Miki Hiasa and Shohei Sakamoto and Hiroshi Omote and Masatoshi Nomura",
year = "2017",
month = "6",
day = "14",
doi = "10.1007/s11302-017-9568-1",
language = "English",
pages = "1--18",
journal = "Purinergic Signalling",
issn = "1573-9538",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Vesicular nucleotide transporter (VNUT)

T2 - appearance of an actress on the stage of purinergic signaling

AU - Moriyama, Yoshinori

AU - Hiasa, Miki

AU - Sakamoto, Shohei

AU - Omote, Hiroshi

AU - Nomura, Masatoshi

PY - 2017/6/14

Y1 - 2017/6/14

N2 - Vesicular storage of ATP is one of the processes initiating purinergic chemical transmission. Although an active transport mechanism was postulated to be involved in the processes, a transporter(s) responsible for the vesicular storage of ATP remained unidentified for some time. In 2008, SLC17A9, the last identified member of the solute carrier 17 type I inorganic phosphate transporter family, was found to encode the vesicular nucleotide transporter (VNUT) that is responsible for the vesicular storage of ATP. VNUT transports various nucleotides in a membrane potential-dependent fashion and is expressed in the various ATP-secreting cells. Mice with knockout of the VNUT gene lose vesicular storage and release of ATP from neurons and neuroendocrine cells, resulting in blockage of the initiation of purinergic chemical transmission. Thus, VNUT plays an essential role in the vesicular storage and release of ATP. The VNUT knockout mice exhibit resistance for neuropathic pain and a therapeutic effect against diabetes by way of increased insulin sensitivity. Thus, VNUT inhibitors and suppression of VNUT gene expression may be used for therapeutic purposes through suppression of purinergic chemical transmission. This review summarizes the studies to date on VNUT and discusses what we have learned about the relevance of vesicular ATP release as a potential drug target.

AB - Vesicular storage of ATP is one of the processes initiating purinergic chemical transmission. Although an active transport mechanism was postulated to be involved in the processes, a transporter(s) responsible for the vesicular storage of ATP remained unidentified for some time. In 2008, SLC17A9, the last identified member of the solute carrier 17 type I inorganic phosphate transporter family, was found to encode the vesicular nucleotide transporter (VNUT) that is responsible for the vesicular storage of ATP. VNUT transports various nucleotides in a membrane potential-dependent fashion and is expressed in the various ATP-secreting cells. Mice with knockout of the VNUT gene lose vesicular storage and release of ATP from neurons and neuroendocrine cells, resulting in blockage of the initiation of purinergic chemical transmission. Thus, VNUT plays an essential role in the vesicular storage and release of ATP. The VNUT knockout mice exhibit resistance for neuropathic pain and a therapeutic effect against diabetes by way of increased insulin sensitivity. Thus, VNUT inhibitors and suppression of VNUT gene expression may be used for therapeutic purposes through suppression of purinergic chemical transmission. This review summarizes the studies to date on VNUT and discusses what we have learned about the relevance of vesicular ATP release as a potential drug target.

KW - Allosteric inhibitor

KW - ATP

KW - Cl dependence

KW - Diabetes

KW - Ketone body

KW - Metabolism

KW - Neuropathic pain

KW - Purinegic signaling

KW - Vesicular nucleotide transporter

KW - VNUT

UR - http://www.scopus.com/inward/record.url?scp=85020692694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020692694&partnerID=8YFLogxK

U2 - 10.1007/s11302-017-9568-1

DO - 10.1007/s11302-017-9568-1

M3 - Article

SP - 1

EP - 18

JO - Purinergic Signalling

JF - Purinergic Signalling

SN - 1573-9538

ER -